Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

6,677 evidence items · page 193 / 268

15 womenFrom 2010 to 2012, 15 HIV-seronegative women initiated DMPA.

KenyaVIH/sidaobserved 2010 to 2012published 2016Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 8 observations

36.3 yearsThe mean age of the 300 enrolled participants was 36.3 years in an HIV care and treatment facility in Western Kenya.

KenyaVIH/sidapublished 2021Journal of medical Internet researchPubMeddocument of 11 observations

41 %The ITBN trial found a 41% reduction in paediatric malaria admissions.

Kenyapaludismepublished 1998Tropical medicine & international health : TM & IHeurope_pmcdocument of 5 observations

Nearly all confirmed malaria cases received antimalarials in Siaya County.

Kenyapaludismeobserved 2021-2023published 2026Malaria journalPubMeddocument of 12 observations

9.7 %GUD prevalence was 9.7% at baseline.

Kenyagenital ulcer disease (GUD)observed baselinepublished 2009Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 4 observationsDOI 10.1097/qai.0b013e3181b065cf

843 ng/mLThe geometric mean P. falciparum histidine-rich protein 2 (PfHRP2) value was 843 ng/mL in uncomplicated malaria.

Kenyapaludismepublished 2021Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument of 6 observations

11 sequencesAmong the 13 clustered sequences, 11 (84.6%) were from GBMSM who tested for HIV less frequently than recommended by Kenyan guidelines.

KenyaVIH/sidaobserved 2019 and 2020published 2024BMC infectious diseasesPubMeddocument of 6 observations

258 patientsA total of 258 patients participated in the study, with 129 HIV mono-infected (controls) and 129 HIV/HBV co-infected (cases).

Kenyahépatite B · VIH/sidapublished 2021Pan African Medical JournalOpenAlexdocument of 10 observations

5.1 %Included studies on chikungunya fever in children were conducted during non-epidemic season in 5.1% of cases.

Kenyachikungunyapublished 2022PLOS global public healtheurope_pmcdocument of 6 observationsDOI 10.1371/journal.pgph.0000914

14.5 %The prevalence of subpatent parasitaemia was 14.5% (95% CI 13.6–15.3%) by individual qPCR.

Kenyapaludismepublished 2022Malaria journalPubMeddocument of 8 observations

In a highland area of Kenya with unstable transmission, the only substantial malaria incidence occurred from April to August 2009.

Kenyapaludismeobserved April to August 2009published 2020The American journal of tropical medicine and hygienePubMeddocument of 3 observations

2.39 aORDisclosure of HIV status to partner was associated with a higher odds of HIV viral suppression (adjusted odds ratio = 2.39, 95% CI: 1.6–3.5) among youth aged 15–24 years living with HIV in rural Kenya and Uganda.

KenyaVIH/sidapublished 2023AIDS carePubMeddocument of 7 observations

14.5 %Rural collection accounted for 14.5% of the collected Anopheles mosquitoes in Kisumu city, Kenya.

Kenyapaludismepublished 2025Malaria journalPubMeddocument of 26 observations

0.17 adolescents_identified_with_HIV_per_facility_per_monthThe mean monthly number of adolescents identified with HIV per health facility increased from 0.17 to 0.26.

KenyaVIH/sidaobserved October 2015 to September 2016published 2022AIDS carePubMeddocument of 16 observations

2.6 %Among 4692 camel nasal swabs collected from 83 calves in 15 homesteads between April and September 2019, 124 (2.6%) screened positive for MERS-CoV RNA.

KenyaMERS-CoVobserved April−September 2019published 2022Viruseseurope_pmcdocument of 6 observationsDOI 10.3390/v14081743

29 %PrEP coverage of 29% was projected to avert approximately 54% of HIV infections and 17% of HIV-related deaths among adults aged 18–49 years over 20 years.

KenyaVIH/sidaobserved 20 yearspublished 2024The lancet. HIVPubMeddocument of 6 observations

2.17 USD_per_client_monthThe estimated financial cost per client-month on PrEP was $2.17 USD for subsidized delivery.

KenyaVIH/sidapublished 2025BMC health services researchPubMeddocument of 13 observations

83 %Shifting to MALDI-TOF MS for malaria vector surveillance would result in an overall direct cost savings of 83%.

Kenyapaludismepublished 2025PloS onePubMeddocument of 5 observations

25 %Sub-Saharan Africa accounts for a quarter of global cervical cancer deaths.

Kenyacancer du col de l'utéruspublished 2026BMC cancerPubMeddocument of 12 observations

63.9 USD_per_personHIV counselling and testing cost 63.90 USD per person.

KenyaVIH/sidaobserved 2019published 2024BMC health services researchPubMeddocument of 8 observations

8.6 %In Kwale County, using microscopy diagnosis, the malaria positivity rate was 8.6% in pregnant women seeking healthcare services at rural health facilities.

Kenyapaludismepublished 2021PloS onePubMeddocument of 15 observations

6.1 %The 95% confidence interval for the increase in eBL incidence per 100 additional lifetime malaria infections was 6.10 to 81.04%.

Kenyaendemic Burkitt lymphoma · paludismepublished 2023Proceedings of the National Academy of Sciences of the United States of AmericaPubMeddocument of 2 observations

13 monthsA possible interruption of malaria transmission occurred for a 13-month period from 2007 to 2008 in Kipsamoite and Kapsisiywa, highland Kenya.

Kenyapaludismeobserved 2007 to 2008published 2020The American journal of tropical medicine and hygienePubMeddocument of 4 observations

25.3 %Missed medication was a DKA precipitant in 25.3% of cases.

Kenyadiabetic ketoacidosis (DKA)observed 2017–2021published 2024BMC endocrine disordersPubMeddocument of 16 observations

30 %Among smear-positive pulmonary tuberculosis/HIV co-infected patients aged 15–49 years in Kenya between 2012 and 2015, 30% of men and 17% of women were aged ≥40 years.

Kenyatuberculose · VIH/sidaobserved 2012-2015published 2020PloS onePubMeddocument of 6 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.